Scilex Holding Company (SCLXW)

USD 0.21

(-23.88%)

Long Term Debt Summary of Scilex Holding Company

  • Scilex Holding Company's latest annual long term debt in 2023 was 17.03 Million USD , up 2462.11% from previous year.
  • Scilex Holding Company's latest quarterly long term debt in 2024 Q1 was 16.32 Million USD , down -4.2% from previous quarter.
  • Scilex Holding Company reported annual long term debt of 665 Thousand USD in 2022, down -99.31% from previous year.
  • Scilex Holding Company reported annual long term debt of 96.68 Million USD in 2021, down -11.54% from previous year.
  • Scilex Holding Company reported quarterly long term debt of 29.03 Million USD for 2024 Q2, up 77.87% from previous quarter.
  • Scilex Holding Company reported quarterly long term debt of 461 Thousand USD for 2023 Q1, down -30.68% from previous quarter.

Annual Long Term Debt Chart of Scilex Holding Company (2023 - 2020)

Historical Annual Long Term Debt of Scilex Holding Company (2023 - 2020)

Year Long Term Debt Long Term Debt Growth
2023 17.03 Million USD 2462.11%
2022 665 Thousand USD -99.31%
2021 96.68 Million USD -11.54%
2020 109.3 Million USD 0.0%

Peer Long Term Debt Comparison of Scilex Holding Company

Name Long Term Debt Long Term Debt Difference
Amgen Inc. 63.17 Billion USD 99.973%
AstraZeneca PLC 23.22 Billion USD 99.927%
Biogen Inc. 7.18 Billion USD 99.763%
Gilead Sciences, Inc. 23.18 Billion USD 99.927%
MIRA Pharmaceuticals, Inc. - USD -Infinity%
Scilex Holding Company 17.03 Million USD 0.0%